Shousha S, Backhouse C M, Dawson P M, Alaghband-Zadeh J, Burn I
Department of Histopathology, Charing Cross Hospital, London, England.
Am J Surg Pathol. 1988 Feb;12(2):130-3. doi: 10.1097/00000478-198802000-00006.
Mammary duct ectasia developed in three postmenopausal patients who had had pituitary chromophobe adenomas. The first patient had bilateral duct ectasia that developed 8 and 11 years after hypophysectomy. The second patient, who also had bilateral ectasia, had a prolactin-producing pituitary adenoma for which bromocriptine was prescribed. The ectasia developed in one breast before commencing bromocriptine therapy, and in the other breast 2 years later. The third patient also had a prolactin-producing pituitary adenoma. Unilateral duct ectasia developed while bromocriptine was taken. The ectasia in all patients was very marked and affected all excised ducts. Cholesterol granulomas were sometimes very extensive. These cases suggest a relationship between certain hypothalamic/pituitary disorders, possibly related to prolactin secretion and the development of mammary duct ectasia in postmenopausal patients.
三名绝经后患有垂体嫌色细胞瘤的患者发生了乳腺导管扩张症。第一名患者在垂体切除术后8年和11年出现双侧导管扩张。第二名患者同样有双侧扩张,患有分泌催乳素的垂体腺瘤,为此开具了溴隐亭。在开始溴隐亭治疗前,一侧乳房出现导管扩张,2年后另一侧乳房也出现扩张。第三名患者也患有分泌催乳素的垂体腺瘤。在服用溴隐亭期间出现单侧导管扩张。所有患者的导管扩张都非常明显,累及所有切除的导管。胆固醇肉芽肿有时非常广泛。这些病例提示某些下丘脑/垂体疾病之间可能存在关联,可能与催乳素分泌以及绝经后患者乳腺导管扩张的发生有关。